Inventor · disambiguated record
Hélène Sicard
Also filed as: SICARD HELENE · SICARD HÉLÈNE
9 granted patents·10 pending applications·41 citations·filing 2003–2024
86Inventor score
Top patents by PatentIndex Score
19 records- 0194US10577419B2KIR3DL2 binding agentsINNATE PHARMA·Filed 2015·Granted Mar 3, 2020·15 cites·10 claims
- 0290US11078275B2Compound that specifically binds to KIR3DL2 for use in the treatment of peripheral T cell lymphomaINNATE PHARMA·Filed 2019·Granted Aug 3, 2021·3 cites·12 claims
- 0390US10174112B2Compound that specifically binds to KIR3DL2 for use in the treatment of peripheral T cell lymphomaINNATE PHARMA·Filed 2017·Granted Jan 8, 2019·9 cites·12 claims
- 0489US10246510B2KIR3DL2 binding agentsINNATE PHARMA·Filed 2013·Granted Apr 2, 2019·9 cites·20 claims
- 0588US11858990B2KIR3DL2 binding agentsINNATE PHARMA·Filed 2020·Granted Jan 2, 2024·2 cites·7 claims
- 0687US2025092130A1Compound that specifically binds to kir3dl2 for use in the treatment of peripheral t cell lymphomaINNATE PHARMA·Filed 2024·Application pending·0 cites
- 0782US10344087B2Treatment of peripheral T cell lymphomaINNATE PHARMA·Filed 2014·Granted Jul 9, 2019·3 cites·7 claims
- 0882US2024425586A1Treatment of peripheral t cell lymphomaINNATE PHARMA·Filed 2024·Application pending·0 cites
- 0980US2024124579A1Kir3dl2 binding agentsINNATE PHARMA·Filed 2023·Application pending·0 cites
- 1079US2024391999A1Treatment with anti-kir3dl2 agentsINNATE PHARMA·Filed 2024·Application pending·0 cites
- 1176US12084498B2Compound that specifically binds to KIR3DL2 for use in the treatment of peripheral T cell lymphomaINNATE PHARMA·Filed 2021·Granted Sep 10, 2024·0 cites·13 claims
- 1271US11999784B2Treatment of peripheral T cell lymphomaINNATE PHARMA·Filed 2019·Granted Jun 4, 2024·0 cites·1 claims
- 1368US11970535B2Treatment with anti-KIR3DL2 agentsINNATE PHARMA·Filed 2020·Granted Apr 30, 2024·0 cites·19 claims
- 1460US2016002345A1A compound that specifically binds to kir3dl2 for use in the treatment of peripheral t cell lymphomaINNATE PHARMA·Filed 2014·Application pending·0 cites
- 1558US2019248895A1Treatment with anti-kir3dl2 agentsINNATE PHARMA·Filed 2017·Application pending·0 cites
- 1648US2006194755A1Compositions and methods for regulating an immune response in a subjectINNATE PHARMA SAS·Filed 2003·Application pending·0 cites
- 1747US2010189681A1Methods of Using Phosphoantigens Together with Interleukin-2 for the Treatment of CancerINNATE PHARMA SA·Filed 2008·Application pending·0 cites
- 1845US2009304688A1Methods and Compositions for Increasing the Efficiency of Therapeutic Antibodies Using Gamma Delta T Cell ActivatorsINNATE PHARMA SA·Filed 2007·Application pending·0 cites
- 1942US2010254940A1Compositions and Methods for Regulating an Immune Response in a SubjectINNATE PHARMA SA·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Hélène Sicard files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →